This presentation will focus on these injectables to achieve the best possible esthetic and therapeutic outcomes. An understanding of facial anatomy, the aging process, and safety issues for injectable therapy is needed to diagnose and recommend aesthetic treatment plans. A review of neurotoxins and dermal fillers, including the mechanism of action, side effects, expected results, and complications with protocols will be discussed. | 1.00 credits (1.00 pharmacology) | $30

This infectious disease has numerous ramifications to navigate long-term. This lecture on Post-Acute Sequela of COVID19 Syndrome (PASC) or long hauler syndrome will discuss the epidemiology, clinical manifestations, and clinical approach to PASC. Advanced Practice Primary Care providers will be faced with treating and managing their long-haul COVID patients and NPACE is pleased to offer this program to help you meet these challenges. | 1.00 credits (0.25 pharmacology) | $27.50

The LGBTQIA+ population has evolved over the past several years to include other gender non-conforming and gender minority populations. The individual needs of each population within this acronym vary and as a result need to have specialized, focused care in order to meet their healthcare needs. These gender and sexual minorities still encounter issues concerning sexuality, identity, gender, and freedom of expression with their healthcare providers. It is a well-documented fact that the majority of healthcare providers today have not been properly educated on how to care for this population therefore, the specific needs pertaining to each individual group represented in this acronym go largely ignored. This session will focus on how to approach the care of LGBTQIA+ patients and address their specific needs in an effort to promote patient-centered care. | 1.50 credits (0.25 pharmacology) | $37.50

This presentation will highlight important steps a primary care provider can take to make certain that their patients are well prepared for a safe trip; that the patient is aware of health hazards when at their travel destination; and what to look out for when back home. | 1.00 credits (0.50 pharmacology) | $27.50

Building upon the revised diagnostic framework of the DSM-5, this presentation defines somatic symptom disorders, reducing the focus upon lacking medical explanations for physical symptoms in order to make the diagnosis of “medically unexplained symptoms.” With the renewed goal of increasing patient access to appropriate treatment, symptoms that are substantially more severe than expected in association with distress and impairment are emphasized. The presentation explores conditions with no medical explanation and conditions where there is some underlying pathology but an exaggerated response. These concepts are operationalized to enhance the nurse practitioner’s skill in assessing, diagnosing, and managing these challenging disorders in a variety of settings. | 1.75 credits (0.50 pharmacology) | $40

The purpose of this presentation is to provide NPs an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest medications available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. This accredited session is made available for through support from Gilead Sciences. | 1.0 credits (1.0 pharmacology) | FREE

This presentation will review health policy basics at both the federal and state levels. Full practice authority and the varied state laws for nurse practitioner practice will be discussed. An exploration into political fundraising and grassroots advocacy along with examples will be presented. | 1.25 credits (0.00 pharmacology) | $30

This session will provide the nurse practitioner with information regarding common pathogens implicated in AECB and community acquired pneumonia in the patient with underlying co-morbidities such as asthma, COPD and alcohol abuse. Current recommendations regarding antimicrobial treatment options will be reviewed in detail. National recommendations for obtaining chest x-ray and sputum for gram staining will also be discussed. | 1.50 credits (1.50 Pharmacology) | $45

The 2018 Agricultural Improvement Act (Farm Bill 2018) authorized by Congress made hemp products containing less than 0.3% tetrahydrocannabinol (THC) legal. However, contrary to popular belief, this bill did not authorize the legal sale of cannabidiol (CBD) products for promotion of any traditional health benefits, yet the sale of CBD products across the United States has significantly increased following its passage. There is currently no formal regulation on CBD products being sold in the United States beyond Epidiolex® which is specifically regulated as a drug via the FDA. Pharmacists need to understand the basics of how CBD acts on the human body, which health claims have been proven via robust clinical trials, and the potential adverse effects and drug interactions that may occur in a patient who uses these unregulated products in conjunction with their prescribed or over-the-counter medication regimen. Pharmacists also need to be able to provide information regarding the sale and regulation of CBD products and the potential issues that may arise given the current legal status of CBD products. | 1.50 credits (1.50 pharmacology) | $40.00

Presentation of Case Studies in Neurology that may be seen in the primary care setting. The case studies will discuss determining the appropriate neurological assessment and evaluation of findings. Each case study will progress through confirming the diagnosis and planning for the patient. These case studies will include seizure disorder, restless leg syndrome, Parkinson disease, muscle spasms. | 1.0 credits (0.33 pharmacology) | $27.50